Chesterfield, MO, United States of America

Peter Harris

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Washington University. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Harris. Retrieved from https://idiyas.com/inventor/peter-harris-yr6c2rxx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter Harris

Introduction

Peter Harris is an accomplished inventor based in Chesterfield, MO (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit growth factor activation enzymes. His work has the potential to impact the treatment of various malignancies and cancer.

Latest Patents

Peter Harris holds 1 patent for his invention titled "Inhibitors of growth factor activation enzymes." This patent relates to compounds that are effective in inhibiting hepatocyte growth factor activator, matriptase, hepsin, Factor Xa, and thrombin. The invention also encompasses methods for using these inhibitor compounds to treat malignancies, pre-malignant conditions, or cancer by administering an effective amount to a subject in need.

Career Highlights

Peter Harris is affiliated with Washington University, where he conducts research and develops innovative solutions in the field of biochemistry. His work is characterized by a commitment to advancing medical science and improving treatment options for patients.

Collaborations

Peter has collaborated with notable colleagues, including Zhenfu Han and James Walter Janetka. These partnerships have contributed to the advancement of research and the development of new therapeutic strategies.

Conclusion

Peter Harris is a notable inventor whose work in inhibiting growth factor activation enzymes holds promise for cancer treatment. His contributions to the field continue to inspire advancements in medical research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…